Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell

H Moch1, P Schraml, L Bubendorf

  • 1Institute for Pathology and Clinics for Urology, University of Basel, Basel, Switzerland. moch@ubaclu.ubibas.ch

The American Journal of Pathology
|May 11, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective analysis of real-world clinical use of comprehensive genomic profiling in solid tumors in Finland 2017-2020.

ESMO real world data and digital oncology·2026
Same author

A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer.

ESMO gastrointestinal oncology·2026
Same author

Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

From wind to seismic signature captured by seismometers in lake Lucerne.

Scientific reports·2025
Same author

Unravelling lung adenocarcinoma with mucinous histology and its translational implications.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Vimentin expression is a novel molecular marker for renal cell carcinoma (RCC) prognosis. This study identified vimentin as a potential diagnostic and prognostic indicator for kidney cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Renal cell carcinoma (RCC) development involves numerous genes and pathways.
  • Current diagnostic and prognostic tools for RCC lack sufficient molecular markers.
  • Identifying novel molecular parameters is crucial for advancing cancer research and treatment.

Purpose of the Study:

  • To develop a rapid method for identifying clinically relevant molecular changes in cancer.
  • To identify and evaluate genes associated with RCC development and prognosis.

Main Methods:

  • cDNA array analysis of 5184 clones to screen for differentially expressed genes between an RCC cell line and normal kidney tissue.
  • Immunohistochemistry on a renal cancer tissue microarray of 532 RCC specimens to assess vimentin expression.

Related Experiment Videos

  • Statistical analysis to correlate vimentin expression with patient prognosis, independent of grade and stage.

    • Main Results:

    • 89 differentially expressed genes were identified, including vimentin.
    • Vimentin expression was frequent in clear cell (51%) and papillary RCC (61%), but rare in chromophobe RCC (4%) and oncocytomas (12%).
    • Vimentin expression was significantly associated with poor patient prognosis (P < 0.007).

    Conclusions:

    • The combination of cDNA and tumor arrays is an effective approach for rapid identification and evaluation of genes in tumor biology.
    • Vimentin is a promising molecular marker for predicting prognosis in renal cell carcinoma.
    • Further research into vimentin's role may improve RCC diagnostics and treatment strategies.